Literature DB >> 16923769

Angiotensin receptor blockers do not increase risk of myocardial infarction.

Ross T Tsuyuki1, Michael A McDonald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923769     DOI: 10.1161/CIRCULATIONAHA.105.594978

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  More about the "ARB MI paradox".

Authors:  Alistair S Hall; Martin H Strauss
Journal:  Heart       Date:  2007-09       Impact factor: 5.994

2.  Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.

Authors:  Ken Yajima; Akira Shimada; Hiroshi Hirose; Yoichi Oikawa; Satoru Yamada; Shu Meguro; Junichiro Irie; Seiko Irie
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

3.  Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.

Authors:  Raisa Serpi; Anna-Maria Tolonen; Olli Tenhunen; Oskari Pieviläinen; Anna-Maria Kubin; Tommi Vaskivuo; Ylermi Soini; Risto Kerkelä; Hanna Leskinen; Heikki Ruskoaho
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

4.  Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits.

Authors:  Shen Li; Yan-Ning Wang; Manabu Niimi; Bo Ning; Yajie Chen; Dedong Kang; Ziyun Wang; Qi Yu; Ahmed Bilal Waqar; Enqi Liu; Jifeng Zhang; Masashi Shiomi; Y Eugene Chen; Jianglin Fan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-17       Impact factor: 8.311

Review 5.  Drug therapy for the secondary prevention of stroke in hypertensive patients: current issues and options.

Authors:  Stephan Lüders
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  A New Option for Therapeutic Management of Patients with Cardiovascular Disease : A Closer Look at the ONTARGET Study.

Authors:  Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

7.  BP goal achievement in patients with uncontrolled hypertension : results of the treat-to-target post-marketing survey with irbesartan.

Authors:  Joachim Schrader; Peter Bramlage; Stephan Lüders; Martin Thoenes; Andreas Schirmer; Dieter W Paar
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 8.  Role of the Renin-Angiotensin-Aldosterone System and Its Pharmacological Inhibitors in Cardiovascular Diseases: Complex and Critical Issues.

Authors:  Claudio Borghi; Francesco Rossi
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-09-24

Review 9.  Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.

Authors:  Moiz M Shafiq; Dileep V Menon; Ronald G Victor
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

Review 10.  Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.

Authors:  Dean M Robinson; Monique P Curran; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.